Will analogs of 1,25-dihydroxyvitamin D 3 (calcitriol) open a new era in cancer therapy?

Onkologie

Volumn 24, Issue 2, 2001, Pages 128-133

  Reichrath, J ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

1,25 Dihydroxyvitamin D 3; Cancer therapy; Vitamin D receptor

Indexed keywords

CALCITRIOL; DNA; NUCLEAR FACTOR; RETINOID X RECEPTOR; VITAMIN D BINDING PROTEIN; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

CANCER; CANCER THERAPY; CELL METABOLISM; DIMERIZATION; DNA BINDING; DRUG EFFICACY; HUMAN; HYPERCALCEMIA; LEUKEMIA; NONHUMAN; REVIEW; SKIN CANCER; TUMOR GROWTH; VITAMIN D METABOLISM;

ANTINEOPLASTIC AGENTS, HORMONAL; CALCITRIOL; CELL DIVISION; CLINICAL TRIALS; HUMANS; LEUKEMIA; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035041590     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050299     Document Type: Review

References (50)

1. 3 in human skin and the physiologic consequences. Science 1980;210: 203-205.
2. 3. Arch Dermatol 1987;123: 1677-1682.
3. 3 by perfused pig skin. J Invest Dermatol 1994;102:796-79S.
4. 3 (calcitriol). J Dermatol Sei 1998;18:118-127.
5. Jones G Analog Metabolism; in Feldman D, Glorieux FH, Pike JW (eds): Vitamin D. San Diego, CA, USA, Academic Press, 1997, pp 973-994.
6. Binderup L, Binderup E, Godtfredsen WO Development of new vitamin D analogs; in Feldman D, Glorieux FH, Pike JW (eds): Vitamin D. San Diego, CA, USA, Academic Press, 1997, pp 1027-1044.
7. 3. J Cell Biochem 1994;56:510-517.
8. 3 in basallateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem 1994; 269:23750-23756.
9. Baker AR, Me Donnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley B W Cloning and expression of full length cDNA encoding human vitamin D receptor. Proc Natl Acad Sei USA 1988;85:3294-3298.
10. Danvish H, DeLuca HF Vitamin D regulated gene expression. Crit Rev Eukaryot Gene Expr 1993;3: 89-116.
11. 3 receptor in target cells. Endocrinology 1988;122: 1224-1230.
12. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979;206:1189-1190.
13. 3 receptors (VDR) in human skin: A comparison of five antibodies. Path Res Pract 1996;192:1-10.
14. 3 receptor in cervical carcinoma. Histochem J 1998;30:561-567.
15. Yu VC, Deisert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG RXRb: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991;67:1251-1266.
16. Carlberg C, Bendik I, Wyss A, Meier E, Slurzenbecker LJ, Grippo JF, Hunziker W Two nuclear signalling pathways for vitamin D. Nature 1993; 361:657-660.
17. 3. Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 1995;231:517-527.
18. Reichrath J, Münßinger T, Kerber A, RochetteEgly C, Chambon P, Bahmer FA, Baum H-P In situ detection of retinoid-X receptor (RXR-α,-β,-γ) expression in normal and psoriatic human skin. Br J Dermatol 1995;133:168-175.
19. Garland CF, Comstock OW, Garland FC, Helsing KJ, Shaw EK, Gorham ED Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 19S9;2:1176-1178r
20. Gorham ED, Garland CF, Garland FC Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990;19:820-824.
21. Lundin AC, Soderkvist P, Eriksson B, BergmanJungestrom M, Wingren S Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 1999;15:2332-2334.
22. Texereau M, Viac J Vitamin D, immune system and skin. Europ J Dermatol 1992;2:25S-264.
23. 3. J Cell Biochem 1992;49:26-31.
24. 3 und seine Analoga als multifunktionelle Steroidhormone. Hautarzt 1994;45:445-452.
25. 3. Proc Natl Acad Sei USA 1981;78:4990-4995.
26. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown under serum-free conditions. J Invest Dermatol 19S6;86:709-714.
27. 3 potentiates the cytotoxic effects of TNF on human breast cancer cells. Mol Cell Endocrinol 1994;106:157-162.
28. 3 receptor in HL-60 cells and related subclones. Mol Cell Endocrinol 1993; 95:51-57.
29. 3 leads to induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996;10:142-153.
30. 3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Endocrinology 2000;141:2548-2546.
31. Schräder M, Bendik I, Becker-Andre M, Carlberg C Interaction between retinoic acid and vitamin D signaling pathways. J Biol Chem 1993;268: 17830-17836.
32. Heyman RA, Mangelsdorf DJ, Dyvk JA, Stein RB, Eichele G, Evans RM.Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid-X receptor. Cell 1992;6S:397-406.
33. 3 on prostatic epithelial cells. Urol Oncol 1995;!: 188-194.
34. 3 analogs and paditaxel on the growth of MCF-7 breast cancer cells in vivo. Breast Cancer Res Treat 1999;3:113-120.
35. 3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res 1999;5:695-703.
36. 3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cells. J Endocrinol 1996;149:327-333.
37. 3; in Feldman D, Glorieux FH, Pike JW (eds): Vitamin D. San Diego, CA, USA, Academic Press, 1997, pp 233-258.
38. 3 prolong the survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sei USA 1983;SO: 201-204.
39. 3. Cancer Res 19S7;47:21-25.
40. 3. Cancer Res 19S5;45: 5426-5430.
41. 3 diminishes tumor-induced myelopoesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother 1995;41:37-45.
42. Albert DM, Marcus DM, Gallo JP, O'Brien JM The anti-neoplastic effect of vitamin D in transgenic mice with retinoblastoma. Invest Ophthalmol Vis Sei 1992;33:2354-2364.
43. 3, hypercalcemia, and groth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Breast Cancer Res Treat 1992:22:133-140.
44. 3 and prostate cancer cell proliferation in vivo. Urology 1995;46:365-369.
45. Lucia MS, Anzano MA, Slayter MV, Amer MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, Roberts AB, Sporn MB Chemopreventive activity of tamoxifen, N-(4hydroxyphenyljretinamide, and the vitamin D analogue, Ro-24531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res 1995;55:5621-5627.
46. 3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 2000;60:2673-2679.
47. Colston KW, Chander SK, Mackay AG, Coombes RC Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 1992;44:693-702.
48. 3, DD-003. Cancer Res 1994;54:514&-5153.
49. 3 synthetic analogs inhibit spontaneous métastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model. Int J Oncol 2000;16:1249-1254.
50. 3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7.12-dimethylbenz[a]anthracene. Anti Cancer Drugs 19912:475-450.